Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q2 FY22 results · Jul–Sep 2021
Krishna Institute of Medical Sciences reported revenue from operations of ₹411.74 crore and net profit of ₹84.25 crore for Q2 FY22 (Jul–Sep 2021), on a consolidated basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 411.74 | — | — | 473.18 | −13.0% |
| Other income | 5.41 | — | — | 4.27 | +26.5% |
| Total income | 417.15 | — | — | 477.45 | −12.6% |
| Profit before tax | 113.16 | — | — | 124.53 | −9.1% |
| Net profit for the period | 84.25 | — | — | 92.03 | −8.4% |
| Attributable to shareholders of the company | 81.72 | — | — | 89.13 | −8.3% |
| EPS, basic (₹) | 10.34 | — | — | 11.48 | −10.0% |
| Net margin (%) | 20.5 | — | 19.4 |
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 284.17 | — | — | 331.51 | −14.3% |
| Other income | 9.34 | — | — | 4.02 | +132.5% |
| Total income | 293.51 | — | — | 335.53 | −12.5% |
| Profit before tax | 94.93 | — | — | 102.13 | −7.0% |
| Net profit for the period | 71.31 | — | — | 76.16 | −6.4% |
| EPS, basic (₹) | 8.91 | — | — | 9.81 | −9.2% |
| Net margin (%) | 25.1 | — | 23.0 |
Consolidated
- Filed with BSE
- 11 Nov 2021, 16:25 IST
- Board meeting
- 10 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Nov 2021, 16:25 IST
- Board meeting
- 10 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE